Mechanism-based inhibition of cytochrome P450 enzymes: An evaluation of early decision making in vitro approaches and drug–drug interaction prediction methods
Authors:
- Kenneth H. GrimeKGKenneth H. Grime
- James BirdJBJames Bird
- Douglas FergusonDFDouglas Ferguson
- Robert J. RileyRRRobert J. Riley
- 1 February 2009
- journal article
- review article
- Published by Elsevier in European Journal of Pharmaceutical Sciences
- Vol. 36 (2-3) , 175-191
Abstract
No abstract availableKeywords
This publication has 68 references indexed in Scilit:
- Integrated in Vitro Analysis for the in Vivo Prediction of Cytochrome P450-Mediated Drug-Drug InteractionsDrug Metabolism and Disposition, 2008
- Mechanism-based inactivation of human cytochrome P450 enzymes: strategies for diagnosis and drug–drug interaction risk assessmentXenobiotica, 2007
- Pharmacokinetic consequences of time-dependent inhibition using the isolated perfused rat liver modelXenobiotica, 2006
- AUTOMATED ASSESSMENT OF TIME-DEPENDENT INHIBITION OF HUMAN CYTOCHROME P450 ENZYMES USING LIQUID CHROMATOGRAPHY-TANDEM MASS SPECTROMETRY ANALYSISDrug Metabolism and Disposition, 2005
- AUTOMATED SCREENING WITH CONFIRMATION OF MECHANISM-BASED INACTIVATION OF CYP3A4, CYP2C9, CYP2C19, CYP2D6, AND CYP1A2 IN POOLED HUMAN LIVER MICROSOMESDrug Metabolism and Disposition, 2005
- IN VITRO-IN VIVO EXTRAPOLATION OF CYP2D6 INACTIVATION BY PAROXETINE: PREDICTION OF NONSTATIONARY PHARMACOKINETICS AND DRUG INTERACTION MAGNITUDEDrug Metabolism and Disposition, 2005
- Lack of Pharmacologic Interaction Between Paroxetine and Alprazolam at Steady State in Healthy VolunteersJournal of Clinical Psychopharmacology, 2004
- MECHANISM-BASED INHIBITION OF HUMAN LIVER MICROSOMAL CYTOCHROME P450 1A2 BY ZILEUTON, A 5-LIPOXYGENASE INHIBITORDrug Metabolism and Disposition, 2003
- Inhibition and Induction of Cytochrome P450 and the Clinical ImplicationsClinical Pharmacokinetics, 1998
- Effect of Zileuton on Theophylline PharmacokineticsClinical Pharmacokinetics, 1995